The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Gilead Sciences; Janssen; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Janssen; Roche; Takeda
Research Funding - Gilead Sciences; Gilead Sciences (Inst); Janssen; Janssen (Inst); Roche; Roche (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche; Takeda
PILLAR-2: A randomized, double-blind, placebo-controlled, phase III study of adjuvant everolimus (EVE) in patients (pts) with poor-risk diffuse large B-cell lymphoma (DLBCL).
 
Thomas E. Witzig
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Consulting or Advisory Role - Amgen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst)
 
Kensei Tobinai
Honoraria - Eisai; Mundipharma; Spectrum Pharmaceuticals; Takeda; Zenyaku Kogyo
Research Funding - Abbvie (Inst); Celgene (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Mundipharma (Inst); Ono Pharmaceutical (Inst); SERVIER (Inst); Takeda (Inst)
 
Luigi Rigacci
No Relationships to Disclose
 
Tongyu Lin
No Relationships to Disclose
 
Takashi Ikeda
No Relationships to Disclose
 
Anna Vanazzi
No Relationships to Disclose
 
Masayuki Hino
Research Funding - Novartis
 
Yuankai Shi
No Relationships to Disclose
 
Jiri Mayer
Research Funding - Novartis; Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Luciano J Costa
Honoraria - Amgen; Sanofi
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Amgen; Sanofi
Research Funding - Amgen
 
Carlos DANIEL Bermudez
No Relationships to Disclose
 
Jun Zhu
No Relationships to Disclose
 
David Belada
No Relationships to Disclose
 
Kamal Bouabdallah
No Relationships to Disclose
 
Joseph Gergi Kattan
No Relationships to Disclose
 
Cassandra Wu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jenna Fan
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Anne-Laure Louveau
Employment - Novartis
 
Maurizio Voi
Employment - Mesoblast (I); Novartis
Stock and Other Ownership Interests - Novartis
 
Franco Cavalli
Honoraria - Abbvie; Celgene; Janssen; Takeda
Consulting or Advisory Role - Mundipharma; Novartis
Research Funding - Mundipharma (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)